UNSPSC 85251715: Diagnosis of malignant neoplasm on the middle lobe, bronchus or lung

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Middle lobe, bronchus or lung. Malignant neoplasm on the Middle lobe, bronchus or lung is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C34. 2

UNSPSC 85251715 Diagnosis of malignant neoplasm on the middle lobe, bronchus or lung is a Commodity code that shows limited alignment with recent state and local procurement activity. The code's nominal scope—clinical diagnosis of a specific lung cancer pathology—does not match the work actually being solicited under this classification in the recent opportunities block. The three most recent opportunities tagged to this code cover diagnostic imaging system implementation, school district special education contracted services, and temporary health professional staffing across ancillary clinical categories; none directly address lung cancer diagnosis or oncology services as the code name suggests.

The opportunities span three different issuing bodies across three states—San Mateo Medical Center (California), Birdville Independent School District (Texas), and Santa Clara Health System (California)—with no apparent pattern of repeat buyers or concentrated activity. The San Mateo opportunity (RFP, due October 21, 2026) solicits an enterprise PACS implementation supporting radiology, cardiology, and dental imaging with EPIC integration, a systems procurement rather than a diagnostic service. The Birdville opportunity (sealed proposal, due October 21, 2026) seeks on-site special education contracted services including diagnostician and speech language therapy roles across 30 campuses. The Santa Clara opportunity (RFQ, due October 7, 2026) establishes a qualified vendor pool for temporary health professional staffing in ancillary categories including diagnostic imaging and audiology, with no guaranteed work volume. The code shows no recent activity concentrated in any particular state or region; the geographic spread reflects only the three discrete opportunities present in the source, with California and Texas each representing one state-level or county-level buyer. The mismatch between the code's oncology-specific diagnosis scope and the general health systems and education procurement work tagged to it suggests this code may see limited or misclassified activity in state and local procurement.